Cardiac oxidation independently leads to uncoupled cardiac NOS and diastolic dysfunction, suggesting BH(4) as a potential therapeutic target.
Cardiac oxidation, independently of vascular changes, can lead to uncoupled cardiac NOS and diastolic dysfunction. BH(4) may represent a possible treatment for diastolic dysfunction.
Silberman et al. (2010) studied this question.